FALLOPIAN TUBE CANCERS
Clinical trials for FALLOPIAN TUBE CANCERS explained in plain language.
Never miss a new study
Get alerted when new FALLOPIAN TUBE CANCERS trials appear
Sign up with your email to follow new studies for FALLOPIAN TUBE CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Real-World check: can a targeted ovarian cancer drug deliver outside clinical trials?
Disease control Not yet recruitingThis study tracks the safety and effectiveness of mirvetuximab soravtansine (MIRV), a drug that targets a protein called folate receptor alpha on cancer cells, in patients with advanced ovarian, fallopian tube, or primary peritoneal cancer. Researchers will observe 400 patients r…
Matched conditions: FALLOPIAN TUBE CANCERS
Sponsor: NING LI-GYN • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Targeted Antibody-Drug could shrink Hard-to-Treat ovarian cancers
Disease control Not yet recruitingThis trial tests a drug called sacituzumab govitecan in people with advanced or recurrent ovarian, fallopian tube, or primary peritoneal cancer that has high levels of a protein called TROP-2. Participants must have already tried standard treatments without success. The drug is g…
Matched conditions: FALLOPIAN TUBE CANCERS
Phase: PHASE1 • Sponsor: Shanghai Gynecologic Oncology Group • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New hope for tough ovarian cancer: drug combo trial launches
Disease control Not yet recruitingThis study tests a combination of two drugs, liposomal irinotecan and enlonstobart, in 30 women with ovarian cancer that no longer responds to platinum chemotherapy. The goal is to see if the combo can shrink tumors and delay cancer growth. Participants receive treatment every tw…
Matched conditions: FALLOPIAN TUBE CANCERS
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New triple therapy aims to stall return of ovarian cancer
Disease control Not yet recruitingThis study tests a combination of three drugs (Benmelstobart, Anlotinib, and low-dose Cyclophosphamide) in 40 women whose ovarian, fallopian tube, or peritoneal cancer has come back. The goal is to see if this mix can keep the cancer from growing for longer. Participants must be …
Matched conditions: FALLOPIAN TUBE CANCERS
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New combo therapy aims to shrink ovarian tumors before surgery
Disease control Not yet recruitingThis study tests whether adding an experimental immunotherapy (Aitua Combination Antibody) to standard chemotherapy can help shrink advanced ovarian cancer more effectively before surgery. About 82 women with stage IIIC-IV high-grade serous ovarian cancer who cannot have optimal …
Matched conditions: FALLOPIAN TUBE CANCERS
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Simple hand and foot moves may ease chemo nerve pain in older cancer patients
Symptom relief Not yet recruitingThis study looks at whether hand and foot exercises can reduce nerve pain (numbness, tingling) and improve quality of life in adults aged 65+ with gynecological cancer who are on chemotherapy. About 74 participants will do these exercises to see if they help with chemotherapy sid…
Matched conditions: FALLOPIAN TUBE CANCERS
Phase: NA • Sponsor: Taipei Veterans General Hospital, Taiwan • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Could a Low-Carb diet boost ovarian cancer therapy?
Knowledge-focused Not yet recruitingThis study examines if different eating patterns, especially low-carbohydrate diets, are linked to better outcomes in women with high-grade serous ovarian cancer who are on maintenance therapy with PARP inhibitors. Researchers will review medical records and survey 600 patients f…
Matched conditions: FALLOPIAN TUBE CANCERS
Sponsor: Tongji Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC